See more : Resona Holdings, Inc. (8308.T) Income Statement Analysis – Financial Results
Complete financial analysis of SS Innovations International, Inc. (SSII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SS Innovations International, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Jiayou International Logistics Co.,Ltd (603871.SS) Income Statement Analysis – Financial Results
- United Airlines Holdings, Inc. (0LIU.L) Income Statement Analysis – Financial Results
- Efecte Oy (EFECTE.HE) Income Statement Analysis – Financial Results
- Orion Group Holdings, Inc. (ORN) Income Statement Analysis – Financial Results
- Sinoma Energy Conservation Ltd. (603126.SS) Income Statement Analysis – Financial Results
SS Innovations International, Inc. (SSII)
About SS Innovations International, Inc.
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.88M | 1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 5.17M | 968.72K | 18.79K | 37.43K | 37.70K | 19.46K | 789.00 | 0.00 |
| Gross Profit | 713.45K | 489.59K | -18.79K | -37.43K | -37.70K | -19.46K | -789.00 | 0.00 |
| Gross Profit Ratio | 12.13% | 33.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 576.17K | 83.28K | 1.00K | 3.00K | 60.87K | 27.13K | 71.17K | 138.38K |
| General & Administrative | 20.81M | 6.09M | 1.41M | 1.10M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | -18.79K | -37.43K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.81M | 6.09M | 1.39M | 1.06M | 3.22M | 913.79K | 938.85K | 324.12K |
| Other Expenses | 0.00 | 279.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.38M | 6.17M | 1.39M | 1.07M | 3.28M | 940.92K | 1.01M | 462.49K |
| Cost & Expenses | 26.55M | 7.14M | 1.41M | 1.10M | 3.32M | 960.38K | 1.01M | 462.49K |
| Interest Income | 129.76K | 239.73K | 118.00 | 6.00 | 0.00 | 58.00 | 84.00 | 31.00 |
| Interest Expense | 523.36K | 162.00K | 0.00 | 1.06K | 0.00 | 0.00 | 27.00K | 22.52K |
| Depreciation & Amortization | 162.62K | 128.90K | 18.79K | 37.43K | 37.70K | 19.46K | 789.00 | 0.00 |
| EBITDA | -20.26M | -5.31M | -1.47M | -1.09M | -3.33M | -940.86K | -1.01M | -462.46K |
| EBITDA Ratio | -344.51% | -380.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -20.67M | -5.68M | -1.41M | -1.10M | -3.32M | -960.38K | -1.01M | -462.49K |
| Operating Income Ratio | -351.52% | -389.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -273.60K | 77.73K | -77.27K | -21.75K | -63.29K | 58.00 | -26.91K | -22.49K |
| Income Before Tax | -20.94M | -5.60M | -1.48M | -1.12M | -3.39M | -960.32K | -1.04M | -484.98K |
| Income Before Tax Ratio | -356.17% | -384.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 3.00 | -1.00 | -2.00 | -3.00 | 2.00 | 0.00 |
| Net Income | -20.94M | -5.60M | -1.48M | -1.12M | -3.39M | -960.32K | -1.04M | -484.98K |
| Net Income Ratio | -356.17% | -384.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.16 | -0.14 | -0.52 | -0.48 | -1.57 | -0.46 | -0.53 | -0.25 |
| EPS Diluted | -0.16 | -0.14 | -0.52 | -0.48 | -1.57 | -0.46 | -0.53 | -0.25 |
| Weighted Avg Shares Out | 128.45M | 40.88M | 2.85M | 2.34M | 2.15M | 2.09M | 1.95M | 1.92M |
| Weighted Avg Shares Out (Dil) | 128.45M | 40.88M | 2.85M | 2.34M | 2.15M | 2.09M | 1.95M | 1.92M |
SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia
Fort Lauderdale, Fla., November 26, 2024 – PRISM MediaWire – SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a...
SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia
• SS Innovations marks a milestone with the successful completion of Indonesia's first robotic cardiac surgery using its SSi Mantra Surgical Robotic System.• Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations successfully performed the first Beating Heart Totally...
SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board
Tim Adams to serve as Independent Board Director FORT LAUDERDALE, FL, September 30, 2024 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board
FORT LAUDERDALE, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population,...
Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System
Fort Lauderdale, FL., September 23, 2024 – PRISM MediaWire – SS Innovations International, Inc.
Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System
FORT LAUDERDALE, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, announced...
SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline
Fort Lauderdale, FL., September 11, 2024 – PRISM MediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population,...
SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline
FORT LAUDERDALE, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today...
SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board
Dr. Moll, founder of Intuitive Surgical, to serve as Vice Chairman FORT LAUDERDALE, FL, September 10, 2024 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board
FORT LAUDERDALE, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population,...
Source: https://incomestatements.info
Category: Stock Reports